Arkolith/Insider Trading/AADI/Form 4

Giacobello Scott M.

CHIEF FINANCIAL OFFICERAadi Bioscience, Inc. (AADI) · full profile →Form 4 · filed Mar 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7K
Net Open-Market Flow
-$7K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2025Sell(S)3K$2.35$7K24K
Mar 1, 2025Option exercise(M)7K——27K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 1, 2025Option exercise(M)7K—$020K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-006318) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML